AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAY 6 - (NewsRx.com & NewsRx.net) -- CXCR4 is expressed in DCIS of the breast and atypical ductal hyperplasia, and may play a key role in the development of these malignancies.
"Recent evidence attributed important influence to chemokines and their receptors on motility, homing, and proliferation of cancer cells at specific metastatic sites," oncologists in Austria explained.
In their study, B.C. Schmid and colleagues at the University of Vienna found that "the CXCL12 (SDF-1alpha) chemokine receptor CXCR4 is expressed in human ductal carcinoma in situ (DCIS) as well as in atypical ductal hyperplasia.
"CXCR4 was expressed in pure DCIS and DCIS with concurrent invasive disease," test results revealed. "In 66% of the samples, atypical ductal hyperplasia was present, and > 92% exhibited positive CXCR4-staining.
"Expression of CXCR4 at this very early step of tumor development indicates a role of this receptor in providing a selective advantage to such cells on their way to metastasizing carcinomas," according to the report.
"These results strengthen the ideas to target chemokine networks involved ...